rosuvastatin
Showing 1 - 25 of 790
Dyslipidemias, Stroke, Acute Ischemic Trial in Ansan, Seoul (combination of high-dose rosuvastatin and ezetimibe, high-dose
Recruiting
- Dyslipidemias
- Stroke, Acute Ischemic
- combination of high-dose rosuvastatin and ezetimibe
- high-dose rosuvastatin single administration
-
Ansan, Gyeonggi-do, Korea, Republic of
- +2 more
May 22, 2023
Mi Q Wave Trial in Rawalpindi (Turbox CRP kit, rosuvastatin 20 mg,, atorvastatin 40 mg)
Completed
- Mi Q Wave
- Turbox CRP kit
- +2 more
-
Rawalpindi, PakistanRawalpindi Medical University
Sep 19, 2023
Healthy Trial in Dallas (Rosuvastatin, Selpercatinib)
Not yet recruiting
- Healthy
- Rosuvastatin
- Selpercatinib
-
Dallas, TexasLabcorp Clinical Research LP
Jun 8, 2023
Healthy Volunteers Trial in Toronto (Obicetrapib, Atorvastatin Calcium, Rosuvastatin Calcium)
Not yet recruiting
- Healthy Volunteers
- Obicetrapib
- +2 more
-
Toronto, Ontario, CanadaMark M Feldman
Oct 10, 2023
Healthy Trial in Salt Lake City (LY3537982, Digoxin, Rosuvastatin)
Not yet recruiting
- Healthy
- LY3537982
- +3 more
-
Salt Lake City, UtahICON Early Clinical & Bioanalytical Solutions
Oct 27, 2023
Drug Drug Interaction Trial in Guangzhou (Digoxin, Rosuvastatin, ZSP1273)
Recruiting
- Drug Drug Interaction
- Digoxin
- +4 more
-
Guangzhou, ChinaThe First Affiliated Hospital of Guangzhou University of Chinese
Jul 13, 2023
Pharmacokinetics, Healthy Volunteers Trial in Brussels (Rosuvastatin, Nirmatrelvir/ritonavir)
Not yet recruiting
- Pharmacokinetics
- Healthy Volunteers
- Rosuvastatin
- Nirmatrelvir/ritonavir
-
Brussels, Bruxelles-capitale, Région DE, BelgiumBrussels Clinical Research Unit
Jun 1, 2023
Healthy Volunteers Trial in Beijing (GP681, Rosuvastatin, Digoxin)
Recruiting
- Healthy Volunteers
- GP681
- +4 more
-
Beijing, ChinaChina-Japan Friendship Hospital
Mar 28, 2023
Non-alcoholic Steatohepatitis Trial (Rosuvastatin 20mg, N-acetyl cysteine, Rosuvastatin and N-acetyl cysteine)
Not yet recruiting
- Non-alcoholic Steatohepatitis
- Rosuvastatin 20mg
- +3 more
- (no location specified)
Oct 29, 2023
Healthy Trial (Dabigatran etexilate (DE), Rosuvastatin, PF-07081532)
Not yet recruiting
- Healthy
- Dabigatran etexilate (DE)
- +2 more
- (no location specified)
Mar 15, 2023
Nonalcoholic Steatohepatitis Trial (Rosuvastatin 20 Mg Oral Tablet, Coenzyme Q10 100 MG Oral Capsule)
Not yet recruiting
- Nonalcoholic Steatohepatitis
- Rosuvastatin 20 Mg Oral Tablet
- Coenzyme Q10 100 MG Oral Capsule
- (no location specified)
Feb 7, 2023
Healthy Trial in New Haven (ARV-471, Rosuvastatin)
Recruiting
- Healthy
- ARV-471
- Rosuvastatin
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Dec 29, 2022
Healthy Individuals Trial in Karachi (Test Drug, Reference Drug)
Recruiting
- Healthy Individuals
- Test Drug
- Reference Drug
-
Karachi, Sindh, PakistanMuhammad Raza Shah
Dec 18, 2022
Myocardial Infarction, Statin Adverse Reaction, HMG-CoA Reductase Inhibitor Toxicity Trial in Korea, Republic of (Rosuzet 10/5
Recruiting
- Myocardial Infarction
- +2 more
- Ezetimibe 10mg + Rosuvastatin 5mg
- Rosuvastatin 20mg
-
Bucheon, Gyeonggido, Korea, Republic of
- +6 more
Sep 2, 2022
Dyslipidemia Trial in Seoul (Rosuvastatin Immediate-Release Tablet (IRT) 10mg, Rosuvastatin orally disintegrating tablet
Recruiting
- Dyslipidemia
- Rosuvastatin Immediate-Release Tablet (IRT) 10mg
- Rosuvastatin orally disintegrating tablet (SUVARO®ODT) 10mg
-
Seoul, Korea, Republic ofDivision of Cardiology, Department of Internal Medicine, Yonsei
Nov 22, 2023
Chronic Kidney Disease Trial in Beijing (Midazolam, dabigatran etexilate, pitavastatin, rosuvastatin and atorvastatin)
Recruiting
- Chronic Kidney Disease
- Midazolam, dabigatran etexilate, pitavastatin, rosuvastatin and atorvastatin
-
Beijing, ChinaPeking University Third Hospital
Feb 27, 2023
